149 related articles for article (PubMed ID: 34605909)
1. Functional annotation and investigation of the 10q24.33 melanoma risk locus identifies a common variant that influences transcriptional regulation of OBFC1.
Cardinale A; Cantalupo S; Lasorsa VA; Montella A; Cimmino F; Succoio M; Vermeulen M; Baltissen MP; Esposito M; Avitabile M; Formicola D; Testori A; Bonfiglio F; Ghiorzo P; Scalvenzi M; Ayala F; Zambrano N; Iles MM; Xu M; Law MH; Brown KM; Iolascon A; Capasso M
Hum Mol Genet; 2022 Mar; 31(6):863-874. PubMed ID: 34605909
[TBL] [Abstract][Full Text] [Related]
2. Neural crest-derived tumor neuroblastoma and melanoma share 1p13.2 as susceptibility locus that shows a long-range interaction with the SLC16A1 gene.
Avitabile M; Succoio M; Testori A; Cardinale A; Vaksman Z; Lasorsa VA; Cantalupo S; Esposito M; Cimmino F; Montella A; Formicola D; Koster J; Andreotti V; Ghiorzo P; Romano MF; Staibano S; Scalvenzi M; Ayala F; Hakonarson H; Corrias MV; Devoto M; Law MH; Iles MM; Brown K; Diskin S; Zambrano N; Iolascon A; Capasso M
Carcinogenesis; 2020 May; 41(3):284-295. PubMed ID: 31605138
[TBL] [Abstract][Full Text] [Related]
3. Multiple Functional Variants at 13q14 Risk Locus for Osteoporosis Regulate RANKL Expression Through Long-Range Super-Enhancer.
Zhu DL; Chen XF; Hu WX; Dong SS; Lu BJ; Rong Y; Chen YX; Chen H; Thynn HN; Wang NN; Guo Y; Yang TL
J Bone Miner Res; 2018 Jul; 33(7):1335-1346. PubMed ID: 29528523
[TBL] [Abstract][Full Text] [Related]
4. A UVB-responsive common variant at chromosome band 7p21.1 confers tanning response and melanoma risk via regulation of the aryl hydrocarbon receptor, AHR.
Xu M; Mehl L; Zhang T; Thakur R; Sowards H; Myers T; Jessop L; Chesi A; Johnson ME; Wells AD; Michael HT; Bunda P; Jones K; Higson H; Hennessey RC; Jermusyk A; Kovacs MA; Landi MT; Iles MM; Goldstein AM; ; Choi J; Chanock SJ; Grant SFA; Chari R; Merlino G; Law MH; Brown KM
Am J Hum Genet; 2021 Sep; 108(9):1611-1630. PubMed ID: 34343493
[TBL] [Abstract][Full Text] [Related]
5. Association of XPG rs17655G>C and XPF rs1799801T>C Polymorphisms with Susceptibility to Cutaneous Malignant Melanoma: Evidence from a Case-Control Study, Systematic Review and Meta-Analysis.
Mohammadreza Niktabar S; Alireza Dastgheib S; Heiranizadeh N; Kargar S; Raee-Ezzabadi A; Jarahzadeh MH; Mohsen Miresmaeili S; Zare-Shehneh M; Neamatzadeh H
Klin Onkol; 2020; 33(3):184-194. PubMed ID: 32683874
[TBL] [Abstract][Full Text] [Related]
6. Influence of TNFalpha and LTalpha single nucleotide polymorphisms on susceptibility to and prognosis in cutaneous malignant melanoma in the British population.
Howell WM; Turner SJ; Collins A; Bateman AC; Theaker JM
Eur J Immunogenet; 2002 Feb; 29(1):17-23. PubMed ID: 11841484
[TBL] [Abstract][Full Text] [Related]
7. Cytokine gene single nucleotide polymorphisms and susceptibility to and prognosis in cutaneous malignant melanoma.
Howell WM; Turner SJ; Theaker JM; Bateman AC
Eur J Immunogenet; 2003 Dec; 30(6):409-14. PubMed ID: 14675394
[TBL] [Abstract][Full Text] [Related]
8. Polymorphisms in the syntaxin 17 gene are not associated with human cutaneous malignant melanoma.
Zhao ZZ; Duffy DL; Thomas SA; Martin NG; Hayward NK; Montgomery GW
Melanoma Res; 2009 Apr; 19(2):80-6. PubMed ID: 19209086
[TBL] [Abstract][Full Text] [Related]
9. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
10. Identification of an enhancer region within the TP63/LEPREL1 locus containing genetic variants associated with bladder cancer risk.
Dudek AM; Vermeulen SH; Kolev D; Grotenhuis AJ; Kiemeney LALM; Verhaegh GW
Cell Oncol (Dordr); 2018 Oct; 41(5):555-568. PubMed ID: 29956121
[TBL] [Abstract][Full Text] [Related]
11. Genetic regulatory and biological implications of the 10q24.32 schizophrenia risk locus.
Wang J; Liu J; Li S; Li X; Yang J; Dang X; Mu C; Li Y; Li K; Li J; Chen R; Liu Y; Huang D; Zhang Z; Luo XJ
Brain; 2023 Apr; 146(4):1403-1419. PubMed ID: 36152315
[TBL] [Abstract][Full Text] [Related]
12. IL-10 promoter polymorphisms influence tumour development in cutaneous malignant melanoma.
Howell WM; Turner SJ; Bateman AC; Theaker JM
Genes Immun; 2001 Feb; 2(1):25-31. PubMed ID: 11294564
[TBL] [Abstract][Full Text] [Related]
13. Gene expression profiling of primary cutaneous melanoma.
Winnepenninckx V; Van den Oord JJ
Verh K Acad Geneeskd Belg; 2007; 69(1):23-45. PubMed ID: 17427873
[TBL] [Abstract][Full Text] [Related]
14. Association of TERC and OBFC1 haplotypes with mean leukocyte telomere length and risk for coronary heart disease.
Maubaret CG; Salpea KD; Romanoski CE; Folkersen L; Cooper JA; Stephanou C; Li KW; Palmen J; Hamsten A; Neil A; Stephens JW; Lusis AJ; Eriksson P; Talmud PJ; Humphries SE; ;
PLoS One; 2013; 8(12):e83122. PubMed ID: 24349443
[TBL] [Abstract][Full Text] [Related]
15. Integrative analysis of liver-specific non-coding regulatory SNPs associated with the risk of coronary artery disease.
Selvarajan I; Toropainen A; Garske KM; López Rodríguez M; Ko A; Miao Z; Kaminska D; Õunap K; Örd T; Ravindran A; Liu OH; Moreau PR; Jawahar Deen A; Männistö V; Pan C; Levonen AL; Lusis AJ; Heikkinen S; Romanoski CE; Pihlajamäki J; Pajukanta P; Kaikkonen MU
Am J Hum Genet; 2021 Mar; 108(3):411-430. PubMed ID: 33626337
[TBL] [Abstract][Full Text] [Related]
16. ICAM-1 polymorphisms and development of cutaneous malignant melanoma.
Howell WM; Rose-Zerilli MJ; Theaker JM; Bateman AC
Int J Immunogenet; 2005 Dec; 32(6):367-73. PubMed ID: 16313300
[TBL] [Abstract][Full Text] [Related]
17. Linkage of cutaneous malignant melanoma/dysplastic nevi to chromosome 9p, and evidence for genetic heterogeneity.
Goldstein AM; Dracopoli NC; Engelstein M; Fraser MC; Clark WH; Tucker MA
Am J Hum Genet; 1994 Mar; 54(3):489-96. PubMed ID: 8116618
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous malignant melanoma and Parkinson disease: Common pathways?
Inzelberg R; Flash S; Friedman E; Azizi E
Ann Neurol; 2016 Dec; 80(6):811-820. PubMed ID: 27761938
[TBL] [Abstract][Full Text] [Related]
19. Identification of modifier genes for cutaneous malignant melanoma in melanoma-prone families with and without CDKN2A mutations.
Yang XR; Pfeiffer RM; Wheeler W; Yeager M; Chanock S; Tucker MA; Goldstein AM
Int J Cancer; 2009 Dec; 125(12):2912-7. PubMed ID: 19626699
[TBL] [Abstract][Full Text] [Related]
20. Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma.
Li C; Larson D; Zhang Z; Liu Z; Strom SS; Gershenwald JE; Prieto VG; Lee JE; Ross MI; Mansfield PF; Cormier JN; Duvic M; Grimm EA; Wei Q
Pharmacogenet Genomics; 2006 Apr; 16(4):253-63. PubMed ID: 16538172
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
